Kidswell Bio
4584.TTSE GROWTHPharmaceutical
Financials · Standalone
| Fiscal year ended | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|---|
| Revenue | ¥6.6bn | ¥4.9bn | ¥2.4bn | ¥2.8bn | ¥1.6bn | ¥967mr |
| Operating income | ¥434m | ¥461m | −¥1.3bn | −¥551m | −¥651m | −¥781m |
| Ordinary income | ¥352m | ¥584m | −¥1.4bn | −¥625m | −¥969mr | −¥956mr |
| Net income (owners) | — | — | — | — | −¥535m | −¥1.0bn |
| Total assets | ¥7.3bn | ¥7.5bn | ¥5.1bn | ¥3.9bn | ¥3.5bnr | ¥3.9bnr |
| Net assets / equity | ¥2.9bn | ¥2.0bn | ¥831m | ¥1.2bn | ¥1.7bnr | ¥1.6bn |
| Operating cash flow | — | — | −¥454m | −¥1.4bn | −¥1.2bn | −¥1.3bn |
| EPS (basic) | ¥5.9 | ¥13.77 | ¥-40.23 | ¥-20.77 | ¥-17.86r | ¥-34.79 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 15
| Period | Form | Figures |
|---|---|---|
| 2025-04-01 → 2026-03-31 | Annual | 164 figures · EDINET |
| 2025-04-01 → 2025-09-30 | Half-year | 66 figures · EDINET |
| 2024-04-01 → 2025-03-31 | Annual | 143 figures · EDINET |
| 2024-04-01 → 2024-09-30 | Half-year | 27 figures · EDINET |
| 2023-04-01 → 2024-03-31 | Annual | 132 figures · EDINET |
| 2022-04-01 → 2023-03-31 | AnnualAmended | 128 figures · EDINET |
| 2023-04-01 → 2023-12-31 | Quarterly Q3 | 44 figures · EDINET |
| 2023-04-01 → 2023-09-30 | Quarterly Q2 | 66 figures · EDINET |
| 2022-04-01 → 2023-03-31 | AnnualAmended | 128 figures · EDINET |
| 2023-04-01 → 2023-06-30 | Quarterly Q1 | 42 figures · EDINET |
| 2022-04-01 → 2023-03-31 | Annual | 128 figures · EDINET |
| 2022-04-01 → 2022-12-31 | Quarterly Q3 | 39 figures · EDINET |
| 2022-04-01 → 2022-09-30 | Quarterly Q2 | 52 figures · EDINET |
| 2022-04-01 → 2022-06-30 | Quarterly Q1 | 37 figures · EDINET |
| 2021-04-01 → 2022-03-31 | Annual | 162 figures · EDINET |
22 more reports are still being processed.